Sederma introduces Matrixyl® Morphomics™

In the continuity of the Matrixyl Inside® range, Matrixyl® Morphomics™ is a newly discovered anti-wrinkle Matrikine™ that brings together the latest scientific technologies and Sederma’s expertise in both peptide research and claim substantiation to offer the best in skin rejuvenation.

Inspired by the diversity of collagen cross-linking in human body tissue, Sederma's R&D teams designed a new lipopeptide with unprecedented benefits on the dermis morphology by activating longevigenes™ and re-establishing the connections between the cell nucleus and the extracellular matrix. Revealed by advanced Proteomics of Youth™ technologies, this unique mechanism of action leads to a visible and significant reduction in the appearance of vertical lines, precisely nasogenian folds, marionette and frown lines, after only six weeks, for happier facial expressions.

With Matrixyl® Morphomics™, time has come to shape the skin’s future.
For more information, please use our online contact form.
--- ENDS ---
About Sederma
Founded in 1964, Sederma became a member of the Croda International Group in 1997. Sederma is dedicated to the development of active ingredients and in the creation of innovative concepts for cosmetics, based on the mastery of biotechnology, fine chemistry and vegetal extraction. Sederma has developed a unique range of actives with substantiated efficacy for facial skin care, body care, sun care, hair care and men’s care. With the acquisition of the company Istituto di Ricerche Biotecnologiche (IRB) by Croda, Sederma is now also offering an array of plant stem cell ingredients with guaranteed efficacy, reproducibility and absolute sustainability.